Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

17.20
-0.1985-1.14%
Volume:294.05K
Turnover:4.96M
Market Cap:118.31M
PE:-0.10
High:17.49
Open:17.15
Low:16.68
Close:17.40
Loading ...

BRIEF-Tonix Pharmaceuticals Holding Corp - Discontinued Enrollment And Terminated Phase 2 Catalyst Study - SEC Filing

Reuters
·
26 Apr

BRIEF-Tonix Pharmaceuticals Presented Data On Potential Mpox Vaccine TNX-801 At World Vaccine Congress Washington 2025

Reuters
·
24 Apr

BRIEF-Tonix Pharmaceuticals Announces Oral Presentation And Panel Participation At The World Vaccine Congress Washington 2025

Reuters
·
16 Apr

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

THOMSON REUTERS
·
16 Apr

BRIEF-Tonix Pharmaceuticals And Makana Therapeutics Announce Collaboration Combining Tonix’S Anti-Cd40l Monoclonal Antibody (Tnx-1500) With Makana’S Genetically Engineered Organs In Preclinical And Clinical Xenotransplantation Studies

Reuters
·
09 Apr

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-Cd40l Monoclonal Antibody (Tnx-1500) With Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

THOMSON REUTERS
·
09 Apr

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

GlobeNewswire
·
09 Apr

Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects

TIPRANKS
·
07 Apr

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

GlobeNewswire
·
07 Apr

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

GlobeNewswire
·
01 Apr

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS Newswire
·
31 Mar

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

ACCESS Newswire
·
29 Mar

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

GlobeNewswire
·
27 Mar

Tonix Pharmaceuticals Shares Jump After FDA Guidance for TNX-102

Dow Jones
·
24 Mar

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires Live
·
24 Mar

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment

MT Newswires Live
·
24 Mar

Tonix Pharmaceuticals Holding Corp - Commercial Planning for Tnx-102 Sl Launch in Q4 2025 Underway

THOMSON REUTERS
·
24 Mar

Tonix Pharmaceuticals Holding Corp - FDA Pdufa Goal Date for Tnx-102 Sl Set for August 15, 2025

THOMSON REUTERS
·
24 Mar

Tonix Pharmaceuticals Announces That FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Tnx-102 Sl for the Management of Fibromyalgia

THOMSON REUTERS
·
24 Mar

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

GlobeNewswire
·
24 Mar